← Leaderboards
Michael John Schnieders
University Of Iowa
$2,340,118
Attributed
$9,080,942
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,080,942 · 3
By mechanism
R01$8,242,350 · 2
T32$838,592 · 1
Top collaborators
- Richard J Smith15 shared
- Terry A Braun10 shared
- Thomas L. Casavant10 shared
- Patrick Breheny5 shared
- Carla M Nester5 shared
- Mark A. Arnold2 shared
- Maria Spies2 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Richard J Smith$33,390,035
- James Bruce Tomblin$14,866,296
- Bruce J Gantz$24,180,995
- Thomas L. Casavant$4,311,937
- Terry A Braun$1,348,217
Others in their field
Other Emerging Leaders on “Genes”
- Leonard Freedman · Leidos Biomedical Research, Inc.$97,908,773
- Yunda Huang · Fred Hutchinson Cancer Center$51,342,169
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Lynn Briscoe · Leidos Biomedical Research, Inc.$41,311,588
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Evan Z Macosko · Broad Institute, Inc.$32,734,698
Research focus
GenesGeneticFoundationsGrantProteinsVariantBaseGenomeGenotypeHearing ImpairmentDeafnessFree EnergyGuidelinesDatabasesHearingClinical CareDeveloped CountriesEtiologyBiologyClinical DiagnosticsDesignClassificationAffectEvaluation
Grant awards (17)
Optimizing Genetic Testing for Deafness for Clinical Diagnostics$579,133
R01 · FY2025 · DC
Iowa Biotech-TP: Predoctoral Program in Biotechnology$413,037
T32 · FY2025 · GM
Optimizing Genetic Testing for Deafness for Clinical Diagnostics$615,513
R01 · FY2024 · DC
Iowa Biotech-TP: Predoctoral Program in Biotechnology$425,555
T32 · FY2024 · GM
Optimizing Genetic Testing for Deafness for Clinical Diagnostics$615,513
R01 · FY2023 · DC
Optimizing Genetic Testing for Deafness for Clinical Diagnostics$615,513
R01 · FY2022 · DC
C3 Glomerulopathy -- A Collaborative Study$627,373
R01 · FY2021 · DK
Optimizing Genetic Testing for Deafness for Clinical Diagnostics$508,845
R01 · FY2021 · DC
C3 Glomerulopathy -- A Collaborative Study$627,373
R01 · FY2020 · DK
Optimizing Genetic Testing for Deafness for Clinical Diagnostics$508,845
R01 · FY2020 · DC
C3 Glomerulopathy -- A Collaborative Study$627,373
R01 · FY2019 · DK
Optimizing Genetic Testing for Deafness for Clinical Diagnostics$480,576
R01 · FY2019 · DC
C3 Glomerulopathy -- A Collaborative Study$627,373
R01 · FY2018 · DK
Optimizing Genetic Testing for Deafness for Clinical Diagnostics$564,086
R01 · FY2018 · DC
Optimizing Genetic Testing for Deafness for Clinical Diagnostics$53,375
R01 · FY2018 · DC
C3 Glomerulopathy -- A Collaborative Study$627,373
R01 · FY2017 · DK
Optimizing Genetic Testing for Deafness for Clinical Diagnostics$564,086
R01 · FY2017 · DC